Global map > Innovations > Western Europe > United Kingdom > Southampton > Synairgen
Synairgen icon
Synairgen Research’s SNG001 inhaled drug, is being tested by the University of Southampton to treat asthma, chronic obstructive pulmonary disease and lower respiratory tract illnesses caused by coronavirus.
Rankings by SemRush
National Ranking
70th
in United Kingdom
Regional Ranking
339th
in Western Europe
Global Ranking
1521st
worldwide
Loading startups...